Becton, Dickinson and Company
BDX • NYSE
Becton, Dickinson and Company is a medical - instruments & supplies company in the healthcare sector trading on NYSE, led by CEO Thomas E. Polen Jr., with a market cap of $47.1B.
CEOThomas E. Polen Jr.
Market Cap$47.1B
Medical - Instruments & Supplies
Healthcare
Employees73.0K
Websitebd.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Becton, Dickinson and Company
Date
Thursday, April 30, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q2 2026
EPS Estimate
$2.77
Revenue Estimate
$4.7B
Earnings History
Past 12 earnings reports for Becton, Dickinson and Company
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 9, 2026 | Q1 2026 | $2.91Est: $2.82 | +3.2% | $5.3BEst: $5.1B | +2.0% |  10-Q |
| Nov 6, 2025 | Q4 2025 | $3.96Est: $3.91 | +1.3% | $5.9BEst: $5.9B | -0.3% | 10-K |
| Aug 7, 2025 | Q3 2025 | $3.68Est: $3.41 | +7.9% | $5.5BEst: $5.5B | +0.4% | 10-Q |
| May 1, 2025 | Q2 2025 | $3.35Est: $3.28 | +2.1% | $5.3BEst: $5.4B | -1.5% | — |
| Feb 5, 2025 | Q1 2025 | $3.43Est: $2.99 | +14.7% | $5.2BEst: $5.1B | +1.1% | 10-Q |
| Nov 7, 2024 | Q4 2024 | $3.81Est: $3.77 | +1.1% | $5.4BEst: $5.4B | +1.1% | 10-K |
| Aug 1, 2024 | Q3 2024 | $3.50Est: $3.31 | +5.7% | $5.0BEst: $5.1B | -1.8% | 10-Q |
| May 2, 2024 | Q2 2024 | $3.17Est: $2.97 | +6.7% | $5.0BEst: $5.0B | +0.1% | 10-Q |
| Feb 1, 2024 | Q1 2024 | $2.68Est: $2.40 | +11.7% | $4.7BEst: $4.7B | -0.5% | 10-Q |
| Nov 9, 2023 | Q4 2023 | $3.42Est: $3.43 | -0.3% | $5.1BEst: $5.0B | +1.3% | — |
| Aug 3, 2023 | Q3 2023 | $2.96Est: $2.91 | +1.7% | $4.9BEst: $4.8B | +0.8% | 10-Q |
| May 4, 2023 | Q2 2023 | $2.86Est: $2.74 | +4.4% | $4.8BEst: $4.7B | +3.0% | 10-Q |